methotrexate - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
DBL METHOTREXATE 50mg/2mL injection BP vial
AUST R: 16314
Active ingredients:
methotrexate

Dosage form:
Injection, solution

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800-675-229

From
28 Jul 2023
to
27 Oct 2023

Shortage status:
Current

Availability:
Limited Availability

Reason:
Manufacturing

Management action:
The sponsor is closely controlling the supply. 
Alternative brand available.
DBL METHOTREXATE 500mg/20mL injection BP vial
AUST R: 47252
Active ingredients:
methotrexate

Dosage form:
Injection, solution

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800-675-229

From
22 Dec 2023
to
16 Feb 2024

Shortage status:
Anticipated

Availability:
Available

Reason:
Manufacturing
Pfizer (Australia) METHOTREXATE 1000mg/10mL injection BP vial
AUST R: 10778
Active ingredients:
methotrexate

Dosage form:
Injection, solution

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800-675-229

Deletion from market:
01 Dec 2023

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability